KORU Medical Systems Reports Record Q4 and Full Year 2025 Revenue, Achieves Positive Operating Cash Flow

KORU Medical Systems reported record revenue and full-year positive operating cash flow for Q4 and FY2025. Preliminary unaudited results showed $10.9 million in Q4 revenue, a 23% increase YoY, and $41.1 million in FY2025 revenue, a 22% increase YoY. The company achieved a $8.9 million ending cash balance, representing positive cash flow in Q4 and the full year. This growth was driven by strength in its core immunoglobulin business and recurring patient base.